All sponsors

NewAmsterdam Pharma

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-33
RECRUITING3
READOUTS ≤12 MONTHS3
Open NewAmsterdam Pharma on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
VERMEER
NCT06982508
P2RecruitingAntioxidant Absorption1002026-09 (+5 mo)
PREVAIL
NCT05202509
P3Active, not recruitingAtherosclerotic Cardiovascular Disease95412026-11
VINCENT
NCT06496243
P2RecruitingDyslipidemias692026-11 (+20 mo)
REMBRANDT
NCT06305559
P3Active, not recruitingLipidemia; Coronary Artery Disease3002027-11 (+11 mo)
RUBENS
NCT07219602
P3Active, not recruitingLipidemia; Type 2 Diabetes (T2DM)3002028-03
SPINOZA
NCT07794670
P2RecruitingPreclinical Alzheimer's Disease4002028-09